• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

    9.980 +0.150 (+1.53%)
    Streaming Delayed Price Updated: 9:57 AM EST, Jan 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 9,780
    Open 9.990
    Bid (Size) 9.710 (100)
    Ask (Size) 10.25 (2,000)
    Prev. Close 9.830
    Today's Range 9.830 - 10.18
    52wk Range 3.200 - 25.00
    Shares Outstanding 19,474,303
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators
    Via ACCESS Newswire
    News headline image
    New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
    Via ACCESS Newswire

    Performance

    YTD
    +12.4%
    +12.4%
    1 Month
    +11.4%
    +11.4%
    3 Month
    -16.7%
    -16.7%
    6 Month
    +104.5%
    +104.5%
    1 Year
    -17.6%
    -17.6%

    More News

    Read More
    News headline image
    New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies Reports Updated Clinical Results
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Reports Updated Clinical Results
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
    Via ACCESS Newswire

    Frequently Asked Questions

    Is NeOnc Technologies Holdings, Inc. - Common Stock publicly traded?
    Yes, NeOnc Technologies Holdings, Inc. - Common Stock is publicly traded.
    What exchange does NeOnc Technologies Holdings, Inc. - Common Stock trade on?
    NeOnc Technologies Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock?
    The ticker symbol for NeOnc Technologies Holdings, Inc. - Common Stock is NTHI on the Nasdaq Stock Market
    What is the current price of NeOnc Technologies Holdings, Inc. - Common Stock?
    The current price of NeOnc Technologies Holdings, Inc. - Common Stock is 9.980
    When was NeOnc Technologies Holdings, Inc. - Common Stock last traded?
    The last trade of NeOnc Technologies Holdings, Inc. - Common Stock was at 01/09/26 09:57 AM ET
    What is the market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock?
    The market capitalization of NeOnc Technologies Holdings, Inc. - Common Stock is 194.35M
    How many shares of NeOnc Technologies Holdings, Inc. - Common Stock are outstanding?
    NeOnc Technologies Holdings, Inc. - Common Stock has 194M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.